Home

BB Biotech reported a 4.8% stake in Black Diamond Therapeutics BDTX · 2,733,547 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.8%
Last report
15.1% · filed 25/02/14
Shares held
2,733,547 sh
Class
Common Stock
Event date
25/03/19
Filed
25/03/21

4.8% stake · below 5%

Stake
4.8%
Last report
15.1%
Since last report
−10.3pp

Black Diamond Therapeutics trades, last 26 weeks

What else happened in Black Diamond Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/17~25/04/18

BB Biotech's other 5% stake reports

  • BB Biotech

    5% stakeAgios Pharmaceuticals

    0% stake

    Filed 25/06/13

  • BB Biotech

    5% stakeMacrogenics

    0% stake

    Filed 25/06/13